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Abstract 
Mouse protein tyrosine phosphatase PTPBR7 is a receptor-like, transmembrane protein that 
is localized on the surface of neuronal cells. Its protein phosphatase activity is reduced upon 
multimerization, and PTPBR7-deficient mice display motor coordination defects. Extracellular 
molecules that may influence PTPBR7 activity, however, remain to be determined. We here 
show that the PTPBR7 extracellular domain binds to highly myelinated regions in mouse brain, 
in particular the white matter tracks in cerebellum. PTPBR7 deficiency does not alter this 
binding pattern, as witnessed by RAP in situ staining of Ptprr
-/- mouse brain sections. Additional 
in situ and in vitro experiments also suggest that sugar moieties of heparan sulphate and 
chondroitin  sulphate  glycosaminoglycans  are  not  critical  for  PTPBR7  binding.  Candidate 
binding proteins were affinity-purified exploiting the PTPBR7 extracellular domain and iden-
tified by mass spectrometric means. Results support the suggested link between PTPRR 
isoforms and cerebellar calcium ion homeostasis, and suggest an additional role in the process 
of cell-cell adhesion. 
Key words: cerebellum; RAP in situ; extracellular domain; ligand protein; PTPRR; protein tyrosine 
phosphatase; mass spectrometry. 
Introduction 
Molecular and cellular mechanisms that underlie 
the  development  and  function  of  the  vertebrate 
nervous system include signalling events by cell ad-
hesion molecules (CAMs) and Receptor Tyrosine Ki-
nases [1, 2]. Receptor Protein Tyrosine Phosphatases 
(RPTPs)  regulate  phosphotyrosine  signalling  by 
counteracting  the  tyrosine  kinases  [3].  RPTPs  show 
strong developmental expression in the central (CNS) 
and peripheral nervous system, coinciding with sig-
nificant  events  such  as  axogenesis,  target  contact, 
synaptogenesis  and  plasticity  [4,  5].  The  structural 
resemblance  of  many  RPTPs  to  neural  CAMs  (for 
example  Immunoglobulin-like  domains  and  Fibron-
ectin type III domains) has made them candidate re-
ceptors  for  contact-mediated  cues  encountered  by 
growth cones. Indeed in vivo roles for RPTPs in neural 
development and function have been shown [3, 4].  
Although  numerous  downstream  effectors  of 
RPTP  signalling  have  been  identified,  the  ligands 
have  been  discovered  for  only  a  small  number  of 
RPTPs [6]. The CAM-like subfamily members RPTPμ, 
RPTPκ,  RPTPλ  and  RPTPδ  all  display  homophilic 
interactions that are important in cell adhesion pro-
cesses [6, 7]. Although RPTPσ and PTP-LAR have an 
extracellular segment that is similar to these homo-
philic RPTPs, they rather bind to multiple other ex-
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tracellular proteins. RPTPδ, RPTPσ and PTP-LAR all 
three  bind  netrin-G  ligand-3  (NGL-3)  [8].  RPTPσ 
binds nucleolin, alpha latroxin, contactin, the heparan 
sulphate (HS) proteoglycans agrin and collagen ΧVІІІ, 
and chondroitin-sulphate (CS) produced by astroglia 
[9-13].  A  splice  form  of  human  PTP-LAR  binds  the 
laminin-nidogen complex, a major component of the 
extracellular  matrix  that  modulates  neurite  out-
growth,  proliferation  and  differentiation  [14].  The 
Drosophila  homolog  DLAR  influences  the  develop-
ment  of  synapses  through  the  binding  of  two  HS 
proteoglycans,  syndecan  and  dallylike,  that  have 
positive and negative effects, respectively, on its PTP 
activity [7]. The homologous RPTPγ and RPTPζ each 
bind to distinct contactin family members [15]. In ad-
dition,  RPTPζ  can  interact  with  tenascin  and  plei-
othropin but, intriguingly, only for the latter an effect 
on  activity  was  reported  [16].  Pleiothropin  binding 
resulted  in  RPTPζ  dimerisation  and  inactivation,  as 
had been found for several other RPTPs upon the ar-
tificial induction of dimers [6].  
PTPBR7, a receptor-type isoform that is encoded 
by the mouse Ptprr gene, appears on the cell surface as 
a homomultimeric protein that displays  a much re-
duced  phosphatase  activity  when  compared  to  the 
monomeric  Ptprr-encoded,  cytosolic  variants  [17]. 
Prenatally, PTPBR7 is expressed in spinal ganglia and 
in  Purkinje  precursor  cells  within  the  developing 
cerebellum. After birth, PTPBR7 transcripts gradually 
decrease in the maturing Purkinje cells (PCs) and re-
main  expressed  throughout  all  other  brain  regions 
[18], suggestive of a neurodevelopmental role. Unex-
pectedly, Ptprr knockout mice did not display overt 
brain  malformations  but  rather  performed  quite 
poorly in various locomotive tests [19], reminiscent of 
findings in ataxic animal models with deficits in cer-
ebellar calcium ion homeostasis [20].  
Here we report on the ligand binding potential 
of the PTPBR7 extracellular segment, which does not 
contain any known CAM-like or protein interaction 
motifs. Using Receptor Alkaline Phosphatase  in situ 
(RAP in situ)  methodology  [21, 22] we demonstrate 
PTPBR7 ectodomain binding to myelinated regions in 
mouse brain. Affinity purification and identification 
of associating proteins supports a role for PTPBR7 in 
cell-cell adhesion and Ca2+-regulated processes in the 
mouse brain. 
Materials and methods 
RT-PCR and cloning 
C57BL/6 mouse brain  RNA preparations were 
subjected to RT-PCR to obtain cDNA fragments en-
coding the extracellular domain of PTPBR7, including 
its signal peptide. Approximately 5 µg of total RNA 
was reverse-transcribed by random hexamers prim-
ing and the SuperScript first-strand synthesis system 
(Invitrogen,  Carlsbad,  CA).  Resulting  cDNA  was 
subsequently used in a standard PCR reaction with 
primers bearing restriction sites for EcoRI or KpnI to 
facilitate  cloning.  Primer  sequences  were:  BR7ecto 
forward, 5’- ATGAATTCGCGGCCGCCACCATGAG 
GAGAGCGGTCGGC  -  3’;  BR7ecto226  reverse, 
5’-AGGGTACCTCCTTCTTTGCTCCAGATC-3’; 
BR7ecto225  reverse,  5’-  AGGGTACCTTCTTTGCT 
CCAGATCTTG-3’;  BR7ecto224  reverse,  5’- 
AGGGTACCTTTGCTCCAGATCTTGTC-3’; 
BR7ecto223  reverse,  5’-  AGGGTACCGCTCCAGA 
TCTTGTCTGC-3’;  BE7ecto222  reverse,  5’- 
AGGGTACCCCAGATCTTGTCTGCTTC-3’; 
BR7ecto221  reverse,  5’-  AGGGTACCGATCTTGT 
CTGCTTCGTG-3’;  BR7ecto220  reverse,  5’- 
TGGGTACCCTTGTCTGCTTCGTGCTG-3’.  
The  mammalian  expression  plasmid 
pBG-flexilinker was generated from pBG [11] by in-
serting a linker encoding GGGGSGGGGSP upstream 
of  the  PLAP  open  reading  frame  (Supplementary 
Material: Fig. S1). pBG-flexilinker was linearized us-
ing HindIII and ClaI in order to introduce an adapter 
sequence containing EcoRI and KpnI sites (a hetero-
duplex  of  oligonucleotides  5’-  AGCTGAATTCT 
TAAGGTACCT-3’  and  5’-  CGAGGTACCTTAAG 
AATTC-3’).  The  mammalian  expression  plasmid 
pHLsec [23] and a version containing the extracellular 
domain  of  RPTPµ  (eRPTPµ)  [24]  were  kindly  pro-
vided by Dr. Aricescu. The unique EcoRI and KpnI 
restriction sites allowed insertion of the BR7ecto226 
PCR product into empty pHLsec to generate plasmid 
pHLsec-BR7ecto226-His. 
Antibodies, Glycosaminoglycans (GAGs) and 
GAGs hydrolytic enzymes  
Rabbit polyclonal antiserum α-BR7 directed to-
wards  the  extracellular  domain  of  PTPBR7,  an-
ti-VSV-G tag monoclonal antibody P5D4, and single 
chain  variable  fragment  antibodies  to  HS  (HS4C3), 
CS-A  and  -C  (IO3H10),  and  CS-E  (GD3G7)  are  de-
scribed elsewhere [25-29]. Monoclonal antibody 11-5B 
to CNPase, goat anti-mouse Alexa-Fluor488 antibody, 
and  rabbit  anti-mouse  alkaline  phospha-
tase-conjugated  antibody  were  from  Dakopatts 
(Glostrup,  Denmark),  Millipore  (Billerica,  MA)  and 
Invitrogen,  respectively.  Heparanase  III  (Flavobacte-
rium  heparinum)  was  from  Ibex  Technologies  Inc. 
(Quebec). Bovine kidney HS, shark cartilage CS-A and 
CS-C and chondroitinase ABC (Proteus vulgaris) were 
from Sigma-Aldrich (St. Louis, MO). Shark cartilage 
CS-D and squid cartilage CS-E were from Seikagaku 
(Tokyo, Japan). Int. J. Biol. Sci. 2011, 7 
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Cell culture and transient transfection  
HEK293T cells (ATCC nr. CRL-11268) were cul-
tured in  humidified chambers at 37°C and 5% CO2 
using Dulbecco’s Modified Eagle’s Medium (DMEM) 
reconstituted with pyruvate and glutamine and sup-
plemented with 10% foetal calf serum. When cells in 
T75 cm2 flasks reached 60-70% confluency, they were 
transfected using the DEAE-dextran method [26] and 
cultured in DMEM, 10% foetal calf serum. After 48 
hours conditioned culture media were collected, ster-
ile-filtered and buffered with 20 mM Hepes (pH 7.4) 
[30].  Alkaline  phosphatase  (AP)  activity  in  the  me-
dium was determined using pNPP (Eastman Kodak, 
Rochester, NY) [30]. 
Brain tissue sections and lysates 
Wild  type  and  Ptprr  knockout  mice  of  9  -  12 
months of age were anesthetized and perfused with 
PBS. Whole brains were extracted, snap frozen in liq-
uid nitrogen-cold isopentane, and stored at -80°C or 
used for sagittal and coronal cryosectioning [30]. The 
10 μm cryosections were dried under air flow at RT.  
To  prepare  brain  lysates,  frozen  brains  were 
thawed and homogenized at 4°C in buffer containing 
50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton 
X-100, 1mM PMSF, 10 mM NaF, 1 mM Na3VO4 and 
protease inhibitor cocktail (Roche Diagnostics GmbH, 
Mannheim, Germany). 
Receptor alkaline phosphatase (RAP) in situ 
staining 
For  RAP  in  situ  applications  [30]  cryosections 
were  thawed  at  RT  and  processed  using  published 
methods [31]. The conditioned media containing the 
various AP-fused PTPBR7 extracellular domains were 
used as probe and PLAP-containing medium served 
as  background  control.  Each  assay  employed  200 
µl/section of conditioned culture medium containing 
the  same  AP  activity.  For  some  applications  condi-
tioned media were first concentrated using Vivaspin 
15  membranes  (Sartorius  Stedim  Biotech  GmbH, 
Germany). The  staining  was  at  RT  overnight  using 
NBT-BCIP  (Sigma-Aldrich,  St.  Louis,  MO)  as  sub-
strate [30].  
After  the  RAP  in situ  procedure  sections  were 
briefly  washed  in  milliQ,  embedded  in  a  wa-
ter-soluble embedding and examined on a Leica DM 
LB microscope with HC PL Fluotar objective (Leica 
Microsystem GmbH, Germany). In each experiment 
minimally three sections per condition were analyzed. 
Per  section  three  digital  images  of  cerebellar  white 
matter were taken and for each the mean gray value 
in  three  representative  areas  was  determined  using 
ImageJ  [32].  Statistical  analyses  involved  Student’s 
t-test.  
For some experiments tissue sections received a 
pre-treatment  with  chondroitinase,  involving  an 
overnight incubation at RT in 1 IU/ml chondroitinase 
ABC  digestion  mix  (Sigma-Aldrich)  or  in  chon-
droitinase buffer alone (50 mM Tris-HCl pH 8.0, 60 
mM sodium acetate, 0.02% BSA) as control. Activity of 
the enzyme under these conditions was assessed in-
dependently in a GAG ELISA (see below).  
Immunohistochemistry and immunoblotting 
Cryosections  were  briefly  rinsed  at  RT  in  TBS 
and fixed for 10 minutes in acetone at -20°C. After 2 
washes,  endogenous  mouse  immunoglobulins  were 
blocked using the VECTOR M.O.M Immunodetection 
Kit  (VECTOR  Laboratories,  Inc.  Burlingame,  CA). 
After  blocking,  sections  were  washed  twice  in  TBS 
and  pre-incubated  10  minutes  in  primary  antibody 
M.O.M. Diluent in TBS supplemented with 2% Goat 
Serum. Sections were then incubated for 2 hours at RT 
with  anti  CNPase  (1:100  dilution),  washed  twice  in 
TBS  and  incubated  for  1  hour  at  RT  with 
goat-anti-mouse-conjugated  Alexa-Fluor488  (1:500 
dilution). Finally, sections were washed twice in TBS, 
embedded in Mowiol (Sigma-Aldrich) and analyzed 
by fluorescence microscopy (Leica DMRA). 
For  immunoblotting,  conditioned  medium  was 
mixed  with  sample  buffer,  subjected  to  SDS-PAGE 
and  blotted  onto  PVDF  membranes  by  elec-
tro-transfer. Membranes were incubated with rabbit 
polyclonal antiserum α-BR7 (1:3000 dilution) in TBS 
containing 0.5% Tween 20 and 3% BSA, followed by 
Alexa-Fluor680- conjugated goat-anti-rabbit antibody 
(1:10000 dilution) in the same buffer. Immunoreactive 
bands were visualized on an Odyssey infrared imag-
ing system (LI-COR Biosciences, Lincoln, NE). 
Affinity purification using His-tagged PTPBR7 
ectodomain 
His-Select  Nickel  affinity  gel  (Sigma-Aldrich) 
was washed in washing buffer (50 mM Tris-HCl, pH 
8.0; 300 mM NaCl; 1mM PMSF) and incubated on an 
orbital  shaker  for  2  hours  at  4˚C  with  conditioned 
medium  from  cells  expressing  BR7ecto226-His,  the 
His-tagged RPTPµ extracellular domain [24], or with 
medium from untransfected control cells. Beads were 
then  collected  and  washed  3  times  with  washing 
buffer  containing  10  mM  imidazole.  Subsequently, 
beads were incubated with brain lysate overnight at 
4°C on an orbital shaker. Beads were again collected 
and washed in washing buffer with 1% Triton X-100 
and 150 mM NaCl. Bound proteins were eluted in the 
same  buffer  containing  250  mM  imidazole.  Eluates Int. J. Biol. Sci. 2011, 7 
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were mixed with sample buffer, boiled and subjected 
to  SDS-PAGE.  Following  staining  with  Coomassie 
Brilliant Blue, relevant parts were sliced out and used 
for LC-MS analysis (see below). 
GAG ELISA 
GAG  binding  to  the  extracellular  domain  of 
PTPBR7  was  tested  using  a  modified  ELISA  set-up 
[25]. 100 µl of HS, CS-A, CS-C, CS-D or CS-E (all 10 
μg/ml)  were  coated  in  96-well  microplates  at  RT 
overnight. Excess GAGs was removed by washing 6 
times in ELISA buffer (0.2 M NaCl in PBST). Wells 
were blocked at RT for 1 hour using 3% cold water 
fish skin gelatin in ELISA buffer. After 6 washes dif-
ferent  dilutions  of  conditioned  medium  containing 
BR7ecto226  AP-tagged  protein  were  added  to  the 
wells and incubation was for 1.5 hours at RT in the 
dark.  Following  another  6  washes,  100  μl  of  phos-
phatase reaction mix (1 mg/ml pNPP in SEAP buffer 
[30])  per  well  were  added.  After  incubating  for  2 
hours at RT absorbance at 405 nm was recorded using 
a  Wallac  Victor  3  reader  (Perkin  Elmer,  Waltham, 
MA).  
Some of the CS-A, CS-C and CS-E -coated mi-
croplate wells were used to check chondroitinase ABC 
enzyme  activity.  Following  an  overnight  digestion 
with 1 IU/ml chondroitinase ABC and several washes 
with PBST, these wells were incubated with 100 μl of 
VSV-tagged  CS-specific  single-chain  variable  frag-
ment  antibodies  (1:10  dilution).  Subsequent  incuba-
tions were done using anti-VSV monoclonal antibody 
P5D4 (1:10 dilution) followed by AP-conjugated rab-
bit anti-mouse antibody (1:1000). After 6 washes, 100 
µl of 1 mg/ml pNPP in SEAP buffer [30] was added 
per well and absorbance at 405 nm was recorded.  
In-Gel digestion 
Coomassie Brilliant Blue-stained gel bands were 
minced and destained by 3 consecutive washes in 750 
µl buffer containing 200 mM ammonium bicarbonate 
in  50%  (v/v)  acetonitrile  for  30  min  at  30°C.  After 
drying the gel pieces in a Speedvac (Thermo Savant, 
Holbrook, USA), 200 µl trypsin solution (0.002 µg/µl 
in a 50 mM ammonium bicarbonate buffer solution, 
pH 8.0) was added and allowed to be absorbed by the 
gel for 45 min on ice. Gel bands were completely im-
mersed by adding additional 800 µl buffer solution 
and  incubated  at  37°C  overnight.  The  supernatant 
was recovered, and the resulting peptides  were ex-
tracted  twice  with  500  µl  of  60%  (v/v)  acetonitrile, 
0.1% (v/v) formic acid. The pooled peptide extracts 
were dried in a SpeedVac and resuspended in 15 µl 
2%  (v/v)  acetonitrile,  0.1%  (v/v)  formic  acid  for 
analysis  by  liquid  chromatography  tandem  mass 
spectrometry (LC-MS/MS). 
LC-ESI-FT-MS/MS 
A volume of 5 µl of each fraction was analyzed 
independently  using  a  fully  automated  LC-MS/MS 
setup.  Peptides  were  first  separated  on  an  Agilent 
1200 chromatographic system (Agilent, Santa Clara, 
CA, USA) and on-line measured on a LTQ-FT Ultra 
mass  spectrometer  (Thermo  Fisher  Scientific,  Wal-
tham, MA, USA). The samples were first loaded and 
desalted  on  a  (5  mm  x  0.3  mm)  Zorbax  300SB-C18 
trapping column at a 4 µl/min flow rate using a 2% 
(v/v) acetonitrile, 0.1% formic acid buffer, and then 
separated on a (150 mm x 75 µm) Zorbax 300SB-C18 
analytical column (Agilent) by a 50 min linear gradi-
ent ranging from 2% (v/v) to 80% (v/v) acetonitrile, 
0.1%  formic  acid  at  a  0.3  µl/min  flow  rate.  The 
LC-effluent  was  directly  coupled  to  a  Triversa  Na-
noMate ESI source (Advion, Ithaca, NY, USA), work-
ing  in  nano-LC  mode  and  equipped  with  a  D-chip 
whereon a 1.55 kV voltage was supplied. During the 
LC-separation the FT-ICR mass analyzer acquired MS 
scans  at  100,000  resolution,  the  3  most  intense  pre-
cursor peptides for each MS scan were automatically 
selected and fragmented by the LTQ ion trap mass 
analyzer. 
Mass spectrometry data handling 
Raw  LC-ESI-FT-MS/MS  data  were  analyzed 
using Mascot Daemon v2.2.2 (Matrix Science. Londen, 
UK). The processed spectra were searched against the 
SwissProt Mus musculus database (Swiss-Prot release 
57.15). Carbamidomethyl (C) and oxidation (HMW) 
were  selected  as  variable  modifications,  and  two 
missed  cleavage  were  allowed  with  trypsin  as  the 
cleaving agent. Decoy database searches were done 
with a tolerance of 10 ppm for the precursor ion and 
0.5 Da in the MS/MS mode. Keratins were excluded 
from the final protein list. Only protein identifications 
with a calculated protein probability higher than 0.99 
and with MS/MS ionscore ≥ 30 were retained. 
Results 
PTPBR7 ectodomain probes for RAP in situ 
To  investigate  whether  the  Ptprr-encoded  re-
ceptor-like isoform PTPBR7 displays ligand binding 
potential, we generated a panel of fusion proteins to 
be  used  in  the  RAP  in  situ  technique  [30].  Briefly, 
seven  cDNA  fragments  encoding  the  extracellular 
domain  of  PTPBR7  were  fused  in-frame  with  the 
PLAP  coding  sequence  via  an  intervening,  flexible 
peptide linker (Supplementary Material: Fig. S1). All Int. J. Biol. Sci. 2011, 7 
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started at PTPBR7 amino acid (aa) codon 1 and ended 
at codon 220, 221, 222, 223, 224, 225 or 226, respec-
tively (Fig. 1A). This variety of probes serves selection 
on the basis of optimal fusion protein yield and con-
formational flexibility required for the binding assay. 
After transfection of HEK293T cells, expression 
levels and sizes of the ectodomain probes were mon-
itored on western blots using antiserum α-BR7 [26]. 
All probes except BR7ecto225 were properly secreted 
in  the  culture  medium  and  displayed  the  expected 
apparent molecular weight of 83 kDa (Fig. 1B). Cor-
rect  folding  was  assessed  by  measuring  alkaline 
phosphatase  (AP)  activity  towards 
4-nitrophenyldisodium  orthophosphate,  pNPP  (Fig. 
1C).  All  conditioned  media,  except  for  BR7ecto225, 
met the minimal AP specific activity requirements for 
RAP in situ purposes [30]. In all subsequent experi-
ments specific AP activities were equalized and un-
fused  PLAP-containing  conditioned  medium  served 
as control.  
PTPBR7 extracellular domain binds to mye-
linated tracts in mouse brain 
The  different  PTPBR7  ectodomain-AP  fusion 
probes, except for BR7ecto225, were used on sagittal 
sections of adult mouse brain. Positive staining was 
observed in regions of the corpus callosum, alveus, 
fimbria fornix, anterior commisure of olfactory bulb, 
hippocampal  area  in  the  cerebrum  and  in  cerebel-
lar-related fiber tracts (Fig. 2), all regions associated 
with high myelination [33]. These RAP in situ-positive 
regions of the cerebrum only partially coincide with 
the areas where the Ptprr gene is expressed as deter-
mined by RNA in situ hybridization [18]. No qualita-
tive differences in the binding patterns were observed 
for  the  various  ectodomain  probes,  indicating  com-
parable binding abilities (data not shown). The pat-
terns are distinct from those obtained using  RPTPσ 
extracellular probes [11, 31], underscoring specificity. 
PTPBR7 extracellular domain binds to white 
matter in mouse cerebellum 
Past  studies  showed  that  gene  Ptprr  displays 
highest expression levels in granular layer and PCs in 
the adult mouse cerebellum [18]. RAP in situ staining 
using the various PTPBR7 ectodomain probes result-
ed in positive signals for white matter of the cerebel-
lum.  Some  staining  was  also  present  in  PCs,  single 
neurons of the granular layer and tracts of the molec-
ular layer (Fig. 3). The pattern observed in the white 
matter  is  reminiscent  of  that  of  myelinating  oli-
godendrocytes, as revealed by 2’-3’-cyclic-nucleotide 
3’-phosphodiesterase  (CNPase)  immunoreactivity 
(Fig. 3D).  
We  next  examined  whether  PTPRR  deficiency 
may have an impact on the localization and level of 
expression of putative PTPBR7 ligands. No apparent 
difference  in  the  BR7ecto226  binding  patterns  was 
observed  when  comparing  wild  type  and  Ptprr 
knock-out cerebellar sections (data not shown). 
An attempt to reduce the staining intensity of the 
BR7ecto226 probe by adding increasing amounts of a 
6-Histidine tagged version of this PTPBR7 extracellu-
lar  segment  (BR7ecto226-His)  was  not  successful 
(Supplementary Material: Fig. S2), leading us to con-
clude that either saturation of binding sites could not 
be  achieved  under  these  conditions  or  that 
AP-mediated  dimerization  [30]  of  the  BR7ecto226 
probe  is  favouring  ligand  binding  over  that  of  the 
monomeric His-tagged competitor. It has been shown 
that monomeric RPTPσ binds less well to ligands un-
der RAP conditions as compared to the dimeric probe 
[34]. 
Assessment of binding to heparan sulphate and 
chondroitin sulphate GAGs  
Sulphated  glycosaminoglycans  (GAGs)  have 
important roles in development and plasticity in the 
postnatal brain [35] and some have turned out to be 
RPTP  ligands  [6].  We  therefore  tested  whether  the 
PTPBR7 ectodomain could directly bind to a panel of 
GAG modifications using a tailored ELISA  protocol 
[25]. Successful coating of purified HS and CS-A, -C, 
-D and -E chains onto microtiter plate wells was con-
firmed by the application of single chain GAG-specific 
antibodies in parallel control wells (data not shown). 
Direct binding of probe BR7ecto226 to the HS and CS 
molecules, as determined by measuring AP activity in 
the wells, could not be demonstrated in this set-up 
(Fig. 4). This may also reflect an essential contribution 
of  the  GAGs  protein  moiety  to  the  binding  and, 
therefore,  we  performed  a  complementary  experi-
ment  using  the  RAP  in  situ  assay.  Removal  of  the 
most abundant GAG modification in the CNS, CS, by 
chondroitinase  ABC  treatment  did  not  alter  the 
staining  pattern  or  the  staining  intensity  of  the 
BR7ecto226 probe on cerebellar tissue sections (Fig. 5). 
Successful  chondroitinase  ABC  treatment  could  be 
confirmed  independently  using  the  aforementioned 
ELISA assay (data not shown). Finally, RAP in situ 
staining patterns showed GAG-mediated basal lami-
na binding for RPTPσ [11] but not for PTPRR probes 
(Figure 4). These findings imply that HS and CS are 
not the major binding sites for the PTPBR7 extracel-
lular domain.  
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Fig. 1. Characterization of PTPBR7 ectodomain fusion proteins used for RAP in situ assays on mouse brain sections. (A) 
Schematic representation of mouse PTPBR7 (72 kDa) and the various BR7ecto probes (83 kDa). Signal peptide (SP), hy-
drophobic (HR) and transmembrane (TM) regions, kinase-interacting motif (KIM), catalytic protein tyrosine phosphatase 
domain (PTP), flexible Glycine linker (Gly linker), Placental alkaline phosphatase enzyme (PLAP) and the segment recognised 
by the -BR7 antiserum are indicated. The seven amino acid residues (position 220, 221, 222, 223, 224, 225 and 226 in 
PTPBR7) that form the seven different junctions between the extracellular domain and the Glycine linker are highlighted in 
bold. Resulting probes are named ‘BR7ecto’ followed by the fusion residue number. (B) Expression and secretion of BR7ecto 
probes  as  detected  on  immunoblots.  Conditioned  culture  media  of  HEK293T  cells  transiently  transfected  with 
pBG-flexilinker-based expression constructs for the various BR7ecto probes (indicated by the respective fusion residue 
number on the top of each lane) were subjected to SDS-PAGE and immunoblotted using rabbit polyclonal -BR7 antiserum. 
The arrowhead points at the position of the BR7ecto probes. Molecular size markers (in kDa) are indicated on the left. (C) 
Graph reporting the alkaline phosphatase activity within the different BR7ecto probe-containing conditioned media as 
determined spectrophotometrically using pNPP as a substrate. Int. J. Biol. Sci. 2011, 7 
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Fig. 2. The PTPBR7 ectodomain binds specifically to highly myelinated regions in mouse brain. RAP in situ assays using 
BR7ecto226 (A), BR7ecto224 (B) and control PLAP protein (C) as a probe were performed on adult mouse brain cryo-
sections. Reddish-purple staining was identified in corpus callosum (cc), alveus (alv), fimbria (fi), columns of the fornix (fx), 
anterior commissure of olfactory bulb (aco), hippocampal fissure (hf) in the cerebrum and cerebellar-related fiber tracts 
(wm). Probes BR7ecto220, BR7ecto221, BR7ecto222 and BR7ecto223 gave identical results. Bar = 1 mm. Int. J. Biol. Sci. 2011, 7 
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Fig. 3. Binding pattern of the BR7ecto226 
probe in adult mouse cerebellum. Low (A) 
and high (B) magnification of the cerebel-
lum show strong staining concentrated in 
white matter (wm). Less intense staining is 
observed in Purkinje cells (pl, arrows), in 
single cells of the granular layer (gl) and in 
tracts (arrowhead) of the molecular layer 
(ml).  (C)  Enlargement  of  the  region  in 
panel  A  (dashed  rectangle)  showing  de-
tailed staining of fiber tracts at the white 
matter  branching.  D)  Using  monoclonal 
antibody  11-5B  immuno-reactivity  for 
CNPase  was  detected  in  white  matter 
(wm), resembling the BR7ecto226 staining 
pattern  (C),  with  fiber  tracts  elongating 
from the white matter into the granular 
layer (gl). Bars represent 1 mm (A) and 0.1 
mm (C,D). Int. J. Biol. Sci. 2011, 7 
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Fig. 4. PTPBR7 ectodomain does not bind to heparan sulphate and chondroitin sulphate moieties. (A) Medium containing 
the BR7ecto226 probe was added to microplate wells previously coated with one of the indicated GAG chains, or with 
coating buffer as a control. Binding was assessed by addition of pNPP as substrate and measuring absorption (ABS) at 405 
nm. Successful coating of the wells was confirmed separately, exploiting GAG-specific antibodies. Intensities did not sig-
nificantly differ in comparison with the uncoated control. Results (n=3) are presented as Mean ± S.D. (B) RAP in situ staining 
of the epidermis (arrow) in mouse embryonic cryosections using BR7ecto226 as a probe. (C) The RPTPσ  ectodomain 
probe displays distinct binding to the basal laminae (arrow), whereas BR7ecto226 does not. Int. J. Biol. Sci. 2011, 7 
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Fig.  5.  Removal  of  CS  chains  does  not  alter  PTPBR7  ectodomain  binding  to  cerebellar  white  matter.  BR7ecto226 
probe-containing medium was incubated on Chondroitinase ABC-treated coronal sections of mouse cerebellum (B), and on 
non-treated control sections (A), according to the RAP in situ procedure. Low magnification images do not show overt 
differences in binding. Chondroitinase ABC activity was confirmed separately, exploiting GAG-specific antibodies (data not 
shown). Sections stained with unfused PLAP-containing medium (C) served as control. (D) Quantification of staining in-
tensities within the white matter. Mean gray values are shown. The experiment was done in triplicate and BR7ecto226 and 
PLAP staining intensities were consistently found to be significantly different. Results (n=3) are presented as Mean ± S.D. 
(p=0.0013). CHON= chondroitinase ABC. No treat = no treatment. Bar = 1 mm. 
 
 
Candidate proteins that bind to the PTPBR7 
extracellular domain 
As  an  approach  to  directly  identify  candidate 
protein molecules that can bind to the PTPBR7 extra-
cellular  segment,  we  exploited  the  BR7ecto226-His 
fusion  protein  to  affinity-purify  such  proteins  from 
mouse brain lysates. Two independent purifications 
were  undertaken  to  address  reproducibility.  Fur-
thermore, a similar procedure was followed using the 
His-tagged RPTPμ extracellular domain [24] as affin-
ity  reagent,  to  verify  specificity  of  the  procedure. 
His-tagged ectodomains were produced in transfect-
ed  HEK293T  cells,  purified  using  nickel  beads  and 
subsequently used to capture mouse brain proteins. 
The  ectodomain-displaying  beads  were  extensively 
washed and the specifically bound proteins were then 
eluted and size-separated on SDS-PAGE. Relevant gel 
lanes were then excised and subjected to enzymatic 
digestion.  Retrieved  peptides  were  subsequently 
identified by means of nanoLC coupled to mass spec-
trometry.  
 Peptides  of  three  different  proteins  were  re-
trieved  reproducibly  in  the  duplicate 
BR7ecto226-purified  samples  (Table  1):  the  guanine 
nucleotide-binding  protein  G(o)  subunit  alpha 
(Gnao1),  the  IgLON  family  cell  adhesion  molecule 
Neurotrimin  (Ntm),  and  α/β  subunits  of  Calci-Int. J. Biol. Sci. 2011, 7 
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um/calmodulin-dependent  kinase  II  (Camk2a/b). 
These  peptides  did  not  overlap  with  those  affini-
ty-purified  using  RPTPμ  extracellular  domain  or 
nickel beads alone as controls and generated protein 
Mascot  scores  above  60,  minimizing  false  positive 
rates.  It  is  of  note  that  PSD-95,  the  most  abundant 
membrane-associated  protein  of  the  post-synaptic 
density fraction, was not present in our isolates. Both 
findings support the specificity of the applied proce-
dure. At first sight it may come as a surprise to find 
cytoplasmic candidates like Gαo and CaMKII when 
using extracellular protein segments as bait but under 
the conditions used there might still be multi-subunit 
protein complexes that could explain co-purification. 
Future experiments should aim at the validation and 
functional testing of the identified binding proteins. 
 
Table 1. Proteins identified by LC/MS-MS and Mascot Search that were affinity-purified from brain lysates using 
BR7ecto226-His as bait. Proteins that had Mascot scores above 60 and did not purify in isolates using an unrelated 
His-tagged bait or nickel beads alone are listed. Data from two independent isolates are shown. A full list of proteins 
identified in this way is provided as (Supplementary Material: Table S1). *CaMKII protein was detectable in control samples 
but Mascot scores (38) were below threshold. Subunits α and β of CaMKII have high sequence identity and could not be 
distinguished in the analysis. 
Protein name 
 
Protein mne-
monic identifier 
Uniprot Acces-
sion number 
Mass 
(kDa) 
Mascot 
scores 
Queries 
matched 
Function 
Guanine nucleotide-binding 
protein G(o) subunit alpha 
Gnao1  GNAO_MOUSE  40  85  2  Modulator / transducer of GPCR sig-
naling. G(o) protein function is not 
clear. GNAO1 mutation implicated in 
breast cancer 
139  5 
Neurotrimin  Ntm  NTRI_MOUSE  38  77  5  Neural cell adhesion molecule of the 
IgLON subfamily of immunoglobulins  31  1 
Calcium/calmodulin- 
dependent protein kinase 
type II 
Camk2a 
Camk2b 
KCC2A_MOUSE 
KCC2B_MOUSE 
54 
60 
153*  4  Prominent kinase in the central nervous 
system, implicated in long-term poten-
tiation and neurotransmitter release  200*  5 
 
 
Discussion 
 The  mouse  gene  Ptprr  encodes  a  receptor-like 
transmembrane  protein  isoform,  PTPBR7,  which  is 
expressed on many cells of neuronal origin [18]. Our 
previous work has shown that PTPBR7 phosphatase 
activity  is  negatively  regulated  through  ho-
mo-multimerisation [17]. Combined with the pheno-
type  displayed  by  Ptprr  knock-out  mice  [19]  this 
prompted us to search for putative PTPBR7 ligands. 
Exploiting  the  RAP  in  situ  strategy  we  localised 
binding sites for the extracellular domain of PTPBR7 
to highly myelinated areas in mouse brain, including 
white  matter  of  the  cerebellum.  While  highly  sul-
phated  GAGs  proved  to  be  ligands  for  RPTPσ  and 
PTP-LAR [7, 9, 11], we found no evidence for an in-
teraction of the PTPBR7 ectodomain with HS and CS 
in vitro or in situ. In parallel, we used the PTPBR7 ex-
tracellular domain to affinity-purify candidate protein 
ligands from brain lysates and used mass spectrome-
try  for  identification.  The  obtained  associating  pro-
teins  (Gαo,  Neurotrimin  and  CaMKII)  point  to 
Ca2+-regulated processes, cell-cell communication and 
adhesion. Immunopurification of endogenous protein 
complexes containing any of these three proteins and 
PTPBR7, exploiting brain lysates from wildtype and 
Ptprr-/- animals, was unsuccessful (our unpublished 
results).  This  may  be  due  to  aspecificity  or  lack  of 
sensitivity of the antibodies used, but could also re-
flect  that  only  a  small  subset  of  the  proteins  is  in-
volved  in  the  interaction  or  that  their  encounter  is 
transient. It is of note that also ERK1/2 MAP kinases, 
well-established  PTPBR7  interactors,  were  not  de-
tected in these experiments, and reports on ERK-PTP 
complexes indeed are based on ectopic expression.  
 We found that highly myelinated tracts in adult 
brain tissue represent preferred sites of PTPBR7 ec-
todomain binding. These regions do not mirror Ptprr 
expression  patterns  as  revealed  by  RNA  in situ  hy-
bridisation [18], which may reflect PTPBR7 localiza-
tion and interactions on neuronal processes far away 
from the cell body. The concordance of PTPBR7 lig-
and  staining  with  myelinating  oligodendrocytes  in 
cerebellar white matter may even point to a role for 
PTPBR7 in the process of myelination. A direct role in 
remyelination  has  been  demonstrated  for  another 
RPTP, RPTPζ/β, whose expression is induced within 
remyelinating oligodendrocytes in multiple sclerosis 
lesions [36]. The locomotive impairment observed in 
Ptprr-/- animals [19], however, is not accompanied by 
obvious  myelination  defects  arguing  against  such  a 
role for PTPBR7. 
Myelination,  neurite  outgrowth  and  synaptic 
plasticity are strongly based on cell adhesion mecha-Int. J. Biol. Sci. 2011, 7 
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nisms [1, 2]. Intriguingly, a cell-cell adhesion molecule 
presented  as  a  candidate  interactor  of  the  PTPBR7 
extracellular  domain;  Neurotrimin  (Table  1).  Neu-
rotrimin is a member of the IgLON family of neural 
cell  adhesion  molecules  that  contains  members  like 
Neuronal  growth  regulator  1,  LSAMP  and 
OBCAM/OPCML. In vitro and in vivo studies indicate 
that IgLON members either enhance or inhibit neurite 
outgrowth  and  synaptogenesis  [37].  Neurotrimin  is 
expressed in cerebellar granule and Purkinje cells and 
its developmental pattern of expression points to roles 
in  axon  fasciculation  and  synaptogenesis  [38]. 
PTPBR7 is expressed at all developmental stages in 
mouse  cerebellar  granular  cells.  In  contrast,  its  ex-
pression in Purkinje cells gradually decreases over the 
first  weeks  after  birth  [18].  The  putative  PTPBR7  – 
Neurotrimin  interaction  may  well  contribute  to 
Purkinje  cell  maturation  and  parallel  fiber  synapto-
genesis,  processes  that  are  essential  for  cerebellar 
functioning in locomotive processes. 
The  identification  of  cytosolic  CaMKII  α/β 
subunits as a candidate interactor that is reproducibly 
purified  using  the  extracellular  domain  of  PTPBR7 
first  came  as  a  surprise.  However,  we  also  found 
CaMKII binding to the tyrosine phosphatase domain 
of  PTPBR7  in  an  independent  glutathione 
S-transferase  pull-down  experiment  (unpublished 
data). Since PTPBR7 is able to form homo-multimers 
[17] it might be that the PTPBR7 ectodomain stably 
associates with full-length PTPBR7 and its associating 
proteins from mouse brain lysate. This may involve 
cell surface-exposed PTPBR7 but could also address 
PTPBR7-containing complexes following its internal-
isation and subsequent vesicular trafficking. Alterna-
tively, other CaMKII-associated transmembrane pro-
teins  may mediate the interaction with  the PTPBR7 
ectodomain probe. A similar type of reasoning may 
underlie the identification of Gαo in BR7ecto226-His 
purified material. 
 CaMKII  is  highly  expressed  in  brain  and  its 
serine/threonine kinase activity is dependent on in-
creased calcium levels. The enzyme is concentrated in 
the post synaptic density (PSD) fraction and is criti-
cally involved in the synaptic plasticity that underlies 
processes of learning and memory [39]. Mice lacking 
CaMKIIα  display  limbic  epilepsy  [40].  Also  Gαo 
functioning has been linked to neuronal calcium sig-
nalling processes and locomotion. The study of ionic 
currents  in  mouse  hippocampal  CA3  neurons  re-
vealed  that  modulation  of  Ca2+  currents  by  G  pro-
tein-coupled receptors is changed and much slower 
recovery kinetics are displayed when  Gαo isoforms 
are lacking [41]. Gαo deficient animals have normal 
brain morphology but suffer from tremors and occa-
sional seizures, display severe motor control impair-
ment and have a reduced life span of only two months 
[42,  43].  Intriguingly,  locomotive  impairment  com-
bined  with  normal  brain  morphology  was  also  ob-
served  in  Ptprr-/-  mice  [19]  and  in  several  mouse 
models that lack cerebellar calcium binding proteins 
[20].  A  functional  interaction  between  PTPBR7  and 
Gαo or CaMKII containing complexes could well ex-
plain such in vivo parallels. 
 In  conclusion,  our  work  puts  forward  highly 
myelinated areas in brain as a source of PTPBR7 lig-
ands. Using the PTPBR7 extracellular domain as bait, 
we identified protein candidates that lend support to 
PTPBR7 involvement in two major processes. On the 
one hand as part of cell-cell adhesion complexes dur-
ing cerebellar development; on the other hand in cal-
cium  ion-regulated  events  that  are  instrumental  in 
neuronal development and plasticity. This provides a 
working hypothesis to start testing the functional im-
plications  of  the  observed  interactions  in  cell  and 
animal models. 
Supplementary Material 
Figure S1: Schematic representation of the 
pBG-flexilinker vector used to generate RAP in situ 
probes. Figure S2: The binding of BR7ecto226 probe to 
the mouse cerebellum is not altered by the PTPBR7 
extracellular domain itself. Table S1: Mascot scores for 
proteins identified by LC‐ESI‐FT‐MS/MS that were 
affinity‐purified from brain lysates. 
http://www.biolsci.org/v07p0978s1.pdf 
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